A South African family is breathing new hope into the lives of children with cystic fibrosis after a generic version of an expensive treatment became available. The disease, which causes a buildup of mucus in the lungs and digestive system, was once a death sentence for most sufferers as young adults.
But now 99.5% cheaper, the generic medicine could be life-saving. A seven-year-old boy, Grant Leitch's question to his mother if his little brother would die from cystic fibrosis highlights how high prices have been crippling access to modern treatments worldwide. The new drug is being sold by pharmaceutical company Vertex for $370,000 a year but a generic manufacturer has reduced the cost to just $2,000 a year.
Years of parent-led campaigning led to this breakthrough and in many countries including Bangladesh, it can be obtained at a much lower price due to different intellectual property laws. The new treatment allows patients to live normal lives, making significant progress since most cystic fibrosis sufferers were dying as young adults.
But now 99.5% cheaper, the generic medicine could be life-saving. A seven-year-old boy, Grant Leitch's question to his mother if his little brother would die from cystic fibrosis highlights how high prices have been crippling access to modern treatments worldwide. The new drug is being sold by pharmaceutical company Vertex for $370,000 a year but a generic manufacturer has reduced the cost to just $2,000 a year.
Years of parent-led campaigning led to this breakthrough and in many countries including Bangladesh, it can be obtained at a much lower price due to different intellectual property laws. The new treatment allows patients to live normal lives, making significant progress since most cystic fibrosis sufferers were dying as young adults.